PLoS ONE (Jan 2019)
Correction: Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0212989.].
PLoS ONE (Jan 2019)
[This corrects the article DOI: 10.1371/journal.pone.0212989.].